6-132816991-T-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001016.4(RPS12):c.266T>G(p.Val89Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001016.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS12 | ENST00000230050.4 | c.266T>G | p.Val89Gly | missense_variant | Exon 5 of 6 | 1 | NM_001016.4 | ENSP00000230050.3 | ||
RPS12 | ENST00000484616.2 | n.484T>G | non_coding_transcript_exon_variant | Exon 5 of 6 | 2 | |||||
SNORA33 | ENST00000363664.1 | n.-228T>G | upstream_gene_variant | 6 | ||||||
SNORD100 | ENST00000408573.1 | n.*114T>G | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.266T>G (p.V89G) alteration is located in exon 5 (coding exon 4) of the RPS12 gene. This alteration results from a T to G substitution at nucleotide position 266, causing the valine (V) at amino acid position 89 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at